Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-In Capital		Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income/(loss)	Non- Controlling Interests
Balance, beginning of period (in shares) at Dec. 31, 2021			121,833,649		36,828,559
Balance, beginning of period at Dec. 31, 2021		$ 3,970,982	$ 1		$ 2,997,211		$ (760,863)	$ 1,688,815	$ 689	$ 45,129
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		1,056,247						1,052,800		3,447
Other comprehensive income (loss)		(330)							(330)
Exercise of stock options and issuance of restricted stock (shares)	[1]		729,977
Exercise of stock options and issuance of restricted stock	[1]	1,377			$ 1,377
Repurchase of common stock (shares)			(14,568,364)		(14,568,364)
Repurchase of common stock		(376,275)					(376,275)
Stock compensation expense		26,901			$ 26,901
Distributions to non-controlling interests of consolidated joint ventures		(31,261)								(31,261)
Changes in non-controlling interests of consolidated joint ventures, net		(782)								(782)
Balance, end of period (in shares) at Dec. 31, 2022			107,995,262		51,396,923
Balance, end of period at Dec. 31, 2022		4,646,859	$ 1		$ 3,025,489		(1,137,138)	2,741,615	359	16,533
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		769,741						768,929		812
Other comprehensive income (loss)		537							537
Exercise of stock options and issuance of restricted stock (shares)	[2]		1,737,330
Exercise of stock options and issuance of restricted stock	[2]	$ 17,013			$ 17,013
Repurchase of common stock (shares)		(2,814,956)	(2,814,956)		(2,814,956)
Repurchase of common stock		$ (127,959)					(127,959)
Stock compensation expense		26,095			$ 26,095
Balance, end of period (in shares) at Dec. 31, 2023			106,917,636		54,211,879
Balance, end of period at Dec. 31, 2023		5,332,286	$ 1		$ 3,068,597		(1,265,097)	3,510,544	896	17,345
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		886,570						883,309		3,261
Other comprehensive income (loss)		1,613							1,613
Exercise of stock options and issuance of restricted stock (shares)	[3]		932,194
Exercise of stock options and issuance of restricted stock	[3]	$ (4,716)			$ (4,716)
Repurchase of common stock (shares)		(5,607,852)	(5,607,852)	[4]	(5,607,852)	[4]
Repurchase of common stock	[4]	$ (351,073)					(351,073)
Stock compensation expense		22,461			$ 22,461
Distributions to non-controlling interests of consolidated joint ventures		(8,756)								(8,756)
Changes in non-controlling interests of consolidated joint ventures, net		(205)								(205)
Balance, end of period (in shares) at Dec. 31, 2024			102,241,978		59,819,731
Balance, end of period at Dec. 31, 2024		$ 5,878,180	$ 1		$ 3,086,342		$ (1,616,170)	$ 4,393,853	$ 2,509	$ 11,645

[1] Dollar amount includes $6.7 million of stock options exercised offset with the value of shares withheld for taxes on the issuance of restricted stock units which equates to $5.3 million

[2] Dollar amount includes $26.4 million of stock options exercised offset with the value of shares withheld for taxes on the issuance of restricted stock units which equates to $9.4 million

[3] Dollar amount includes $10.7 million of stock options exercised offset with the value of shares withheld for taxes on the issuance of restricted stock units which equates to $15.4 million

[4] Dollar amount includes $200.0 million of Accelerated Share Repurchases and $3.5 million for the the 1% excise tax on share repurchases